When you absolutely have to recruit patients on time.
A Phase II Non-Small Cell Lung Cancer is starting at Accell Clinical Research
We have obtained regulatory approval for a Phase II study in patients with NSCLC. The clinical study will be conducted at 6 sites in Russia and will enroll 20 patients.
This Is Your Team. We Make Clinical Trials Happen.